Skip to main content
Premium Trial:

Request an Annual Quote

TwinStrand Biosciences Closes $16M Series A Round

NEW YORK – TwinStrand Biosciences said Tuesday it has closed a $16 million Series A financing round.

Madrona Venture Group led the round, joined by Alexandria Venture Investments, Ridgeback Capital, and Sahsen Ventures. TwinStrand will use the funds to accelerate its commercial pipeline, grow corporate infrastructure, and pursue pharmaceutical partnerships.

The Seattle-based University of Washington spinout is commercializing duplex sequencing technology to detect low-frequency DNA mutations, with applications in areas such as ovarian cancer diagnostics and genotoxicity testing.

"Being able to read our DNA with the breakthrough accuracy of duplex sequencing will have a profound impact on each of our lives," Terry Myerson, venture partner at Madrona, said in a statement. "TwinStrand's innovation is at the forefront of the intersection of life sciences and computer science. "

Previously, the firm raised $5.5 million in seed funding and won $6.4 million in small business innovation research (SBIR) grants.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.